Abstract P3-06-11: Homologous recombination deficiency (HRD) assay predicts response to cisplatin neoadjuvant chemotherapy in patients with triple negative breast cancer
暂无分享，去创建一个
Z. Szallasi | E. Winer | A. Richardson | W. Barry | A. Gutin | J. Reid | J. Garber | N. Tung | N. Birkbak | D. Silver | S. Isakoff | A. Hartman | K. Timms | P. Ryan | Z. Wang | J. D. Iglehart | E. Mayer | C. Neff | Joshua T. Jones | April Greene-Collozi